Core Viewpoint - Zhejiang Gangu Cable Co., Ltd. has withdrawn its application for listing on the Beijing Stock Exchange, marking a significant setback in its efforts to go public after previously failing to secure an IPO on the Shanghai Stock Exchange [2][6][9] Group 1: Company Background - Gangu Cable, established in 2002, specializes in the research, production, and sales of various types of electrical cables, including high, medium, and low voltage power cables [8] - The company reported a net profit exceeding 100 million yuan in 2022, with a continued growth of 12.08% in 2023, reaching 117 million yuan [10] Group 2: Listing Attempts - Gangu Cable initially submitted its IPO application to the Shanghai Stock Exchange in November 2022 but faced delays and ultimately withdrew its application in June 2024 [3][9] - After a year of preparation, the company submitted its listing materials to the Beijing Stock Exchange on September 25, 2025, but did not appear on the acceptance list [4][6] Group 3: Financial Adjustments - In its latest attempt, Gangu Cable reduced its fundraising target from 577 million yuan during its Shanghai IPO attempt to 386 million yuan for the Beijing listing, which included new projects for smart warehousing and information upgrades [9][10] - The company’s revenue for 2023 was reported at 1.727 billion yuan, with a net profit of 117 million yuan, but faced a decline in 2024 with revenue dropping by 3.31% and net profit nearly falling below 100 million yuan [20][19] Group 4: Market Position and Challenges - Gangu Cable is positioned in the second tier of China's cable manufacturing industry, with a revenue of just over 1.7 billion yuan, which is considered low compared to leading companies in the first tier [11][10] - The company’s family-owned structure has raised concerns regarding governance and management stability, especially following the resignation of key executives in early 2025 [14][17] Group 5: Industry Context - Gangu Cable's withdrawal from the Beijing Stock Exchange listing process makes it the sixth company in the second half of 2025 to fail to secure acceptance for its listing application [23][21] - The overall trend indicates increasing scrutiny and higher standards for companies seeking to list on the Beijing Stock Exchange, despite its perceived lower barriers compared to other exchanges [23][21]

星标 ★ IPO日报 精彩文章第一时间推送 本周（4月21日至4月25日），据证监会官网新增披露，西安新通药物研究股份有限公司（下称"新通药物"）、深圳市千分一智能技术股份有限公司 （下称"千分一"）、浙江亘古电缆股份有限公司（下称"亘古电缆"）、北京煜鼎增材制造研究院股份有限公司（下称"煜鼎增材"）、粤芯半导体技术 股份有限公司（下称"粤芯半导体"）等5家公司进行了上市辅导备案。 截至4月25日， 4月披露进行上市辅导备案的公司有18家。2025年以来，IPO辅导备案新增110家。 IPO日报注意到，新通药物是注册制以来，科创板首例未能在批文有效期内启动发行从而IPO失败的公司； 千分一占据主动笔全球25%市场份额；技术大 佬云集的煜鼎增材辅导前完成由雄安新区政府平台领投的B轮融资；广东本土半导体企业粤芯半导体集齐广汽资本、上汽投资、北汽投资参股，融资金额 超过55亿元。 制图：佘诗婕 拿到批文却没上市 具体来看，新通药物成立于2000年，注册资本约3.7亿元，聚焦于慢性乙肝、肝癌、癫痫等重大疾病领域药物研发。 新通药物于4月21日向陕西证监局递交了IPO辅导备案，辅导机构为中信证券。 这不是新通药物第一次 ...